Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Sep 3, 2010

Premium

Shimadzu this week introduced its LCMS-8030 triple quadrupole mass spectrometer.

The instrument features scan speeds of up to 15,000 u/sec and can perform up to 500 MRMs per second, allowing it to keep up with the faster chromatographic peaks provided by high performance chromatography, the company said. Additionally, the instrument comes with software that allows for simple integration of Shimadzu's LC product lines.


HealthLinx this week announced that it has launched sales in Singapore of its protein biomarker-based ovarian cancer diagnostic OvPlex.

The company's Singapore distribution partner Innovation Exchange is offering OvPlex through Quest Laboratories at a cost of SGD$300 ($223) per test. Singapore is the third country in which the test is available after Australia and the United Kingdom.


Protein Discovery this week launched its YPX Yeast Protein Extraction Kit, which extracts proteins from yeast cells without using mechanical disruption.

The YPX kits extract the entire yeast proteome with "near complete efficiency," making it particularly useful for quantitative proteomic workflows, and is faster and produces higher protein yield compared to conventional methods, the company said.


GenScript announced this week that purchases of its magnetic beads products and epitope tag antibodies are 25 percent off until Nov. 30.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.